Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
PHASE3
The primary objective of this study is to compare the progression-free surv...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC-Hope,1845 W Orange Grove Rd
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)
PHASE3
The goal of this clinical study is to find out how the study drug, sacituzu...
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy
PHASE3
The goal of this clinical study is to see if sacituzumab govitecan-hziy (SG...
Status
Active Not Recruiting
Location
Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
PHASE3
The goal of this study is to find out if the experimental product, sacituzu...